Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jul;120(1):150-5.
doi: 10.1016/j.jaci.2007.04.031. Epub 2007 May 23.

Cytokine modulation of atopic dermatitis filaggrin skin expression

Michael D Howell  1 , Byung Eui Kim, Peisong Gao, Audrey V Grant, Mark Boguniewicz, Anna Debenedetto, Lynda Schneider, Lisa A Beck, Kathleen C Barnes, Donald Y M Leung
Affiliations

Cytokine modulation of atopic dermatitis filaggrin skin expression

Michael D Howell et al. J Allergy Clin Immunol. 2007 Jul.

Abstract

Background: Atopic dermatitis (AD) is a chronic inflammatory skin disease that is characterized by a defective skin barrier function. Recent studies have reported mutations of the skin barrier gene encoding filaggrin in a subset of patients with AD.

Objective: We investigated whether reduced filaggrin expression was found in patients with AD who were not carriers of known filaggrin mutations and whether filaggrin expression was modulated by the atopic inflammatory response.

Methods: Filaggrin expression was measured in skin biopsies and cultured keratinocytes using real-time RT-PCR and immunohistochemistry. Filaggrin loss-of-function mutations were screened in a total of 69 subjects.

Results: Compared with normal skin, filaggrin expression was significantly reduced (P < .05) in acute AD skin, with further reduction seen in acute lesions from 3 European American subjects with AD who were heterozygous for the 2282del4 mutation. This was confirmed by using immunohistochemistry. AD skin is characterized by the overexpression of IL-4 and IL-13. Keratinocytes differentiated in the presence of IL-4 and IL-13 exhibited significantly reduced filaggrin gene expression (0.04 +/- 0.01 ng filaggrin/ng glyceraldehyde 3-phosphate dehydrogenase; P < .05) compared with media alone (0.16 +/- 0.03).

Conclusion: Patients with AD have an acquired defect in filaggrin expression that can be modulated by the atopic inflammatory response.

Clinical implications: The atopic immune response contributes to the skin barrier defect in AD; therefore, neutralization of IL-4 and IL-13 could improve skin barrier integrity.

PubMed Disclaimer

Conflict of interest statement

We have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Filaggrin deficiency in AD skin. RNA was isolated from the skin of normal subjects (n=15) and AD patients (n=16) with or without the 2282del4 mutation. Filaggrin gene expression was evaluated using real-time RT-PCR. * and ** indicate significant differences of p<0.05 and p<0.01, respectively.
Figure 2
Figure 2
Decreased filaggrin staining in AD skin. A. Representative paraffin embedded skin biopsies from normal subjects (n=11), AD patients (n=12), AD patients with the 2282del4 mutation (n=3), and patients with lichen planus (n=6) stained for filaggrin are shown. Images were collected at 40× magnification and the scale bar represents 50 μm. B. The intensity of the staining was graded visually on a scale from 0 (no staining) to 5 (the most intense staining). *, **, and *** indicate significant differences of p<0.05, p<0.01, and p<0.001, respectively.
Figure 2
Figure 2
Decreased filaggrin staining in AD skin. A. Representative paraffin embedded skin biopsies from normal subjects (n=11), AD patients (n=12), AD patients with the 2282del4 mutation (n=3), and patients with lichen planus (n=6) stained for filaggrin are shown. Images were collected at 40× magnification and the scale bar represents 50 μm. B. The intensity of the staining was graded visually on a scale from 0 (no staining) to 5 (the most intense staining). *, **, and *** indicate significant differences of p<0.05, p<0.01, and p<0.001, respectively.
Figure 3
Figure 3
Th2 cytokines down-regulate filaggrin gene expression. Primary human keratinocytes were cultured in 0.06 or 1.3 mM of CaCl2 in the presence and absence of IL-4 and IL-13 or IFN-γ for five days. RNA was collected from the cells, and the levels of filaggrin were evaluated by real-time RT-PCR (A) or Immuno-dot Blot (B & C). *, **, and *** indicate significant differences of p<0.05, p<0.01, and p<0.001, respectively, between exposure groups.
Figure 3
Figure 3
Th2 cytokines down-regulate filaggrin gene expression. Primary human keratinocytes were cultured in 0.06 or 1.3 mM of CaCl2 in the presence and absence of IL-4 and IL-13 or IFN-γ for five days. RNA was collected from the cells, and the levels of filaggrin were evaluated by real-time RT-PCR (A) or Immuno-dot Blot (B & C). *, **, and *** indicate significant differences of p<0.05, p<0.01, and p<0.001, respectively, between exposure groups.
Figure 3
Figure 3
Th2 cytokines down-regulate filaggrin gene expression. Primary human keratinocytes were cultured in 0.06 or 1.3 mM of CaCl2 in the presence and absence of IL-4 and IL-13 or IFN-γ for five days. RNA was collected from the cells, and the levels of filaggrin were evaluated by real-time RT-PCR (A) or Immuno-dot Blot (B & C). *, **, and *** indicate significant differences of p<0.05, p<0.01, and p<0.001, respectively, between exposure groups.
See this image and copyright information in PMC

Republished in

References

    1. Leung DY, Bieber T. Atopic dermatitis. Lancet. 2003;361:151–60. - PubMed
    1. Homey B, Steinhoff M, Ruzicka T, Leung DY. Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol. 2006;118:178–89. - PubMed
    1. Warner JO. A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up. J Allergy Clin Immunol. 2001;108:929–37. - PubMed
    1. Bowcock AM, Cookson WO. The genetics of psoriasis, psoriatic arthritis and atopic dermatitis. Hum Mol Genet. 2004;13(Spec No 1):R43–55. - PubMed
    1. Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, Geha RS. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest. 1998;101:1614–22. - PMC - PubMed

Publication types